GLP Watchdog

altRX vs Brello Health

altRX has an open FDA warning letter dated June 8, 2026. Brello Health has none. No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Brello Health

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Brello Health logo

Brello Health

8.1/10

FDA warning letters
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
Lowest standing price
$89/moCompounded semaglutide injection
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
States
All 50 states
40 states and DC
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit altRX
Visit Brello Health

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Brello Health pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Brello Health 8.1). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Brello Health has none.

  2. 02

    altRX names four pharmacies. Brello Health names SouthEnd Pharmacy, a 503A pharmacy.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate.

  4. 04

    Only altRX lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    AltRX covers 10 states Brello Health does not.

  6. 06

    altRX states you can cancel at any time; Brello Health holds you to a 3-month prepay (6-month plan optional).

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Brello Health

Compounded semaglutide injection

$89/mo

$1,068 a year

$157.72/mo

3-month prepaid plan; not compared

Compounded tirzepatide injection

$149/mo

$1,788 a year

$176.69/mo

6-month prepaid plan; not compared

Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits
Cancel any time
Yes, stated
No
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
3-month prepay (6-month plan optional)
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed

Read off each seller’s own pages. altRX: September 28, 2026. Brello Health: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Brello Health does not price
  • Lists 50 states against 40
  • States you can cancel at any time
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Brello Health

8.1/10
  • No FDA warning letter on record
  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

Scores

altRX 8.8 · Brello Health 8.1 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
6.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
10.0

Accessibility10%

10.0A
vs
B
8.4

Support10%

7.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Brello Health: questions

altRX has an open FDA warning letter dated June 8, 2026. Brello Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Brello Health names SouthEnd Pharmacy, a 503A pharmacy. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Brello Health has a minimum term (3-month prepay (6-month plan optional)).
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Brello Health pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Brello Health 8.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks